EMG
FOMX

ETF Managers Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

ETF Managers Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-114,087
Closed -$374K – 566
2019
Q4 		$374K Sell
114,087
-4,356
-4% -$13.8K 0.01% 300
2019
Q3 		$364K Buy
118,443
+13,083
+12% +$36.8K 0.01% 288
2019
Q2 		$253K Buy
105,360
+25,949
+33% +$77.5K 0.01% 302
2019
Q1 		$298K Sell
79,411
-2,561
-3% -$9.6K 0.01% 265
2018
Q4 		$294K Buy
81,972
+32,773
+67% +$143K 0.01% 268
2018
Q3 		$282K Buy
+49,199
New +$281K 0.01% 237
2018
Q2 		– Sell
-32,021
Closed -$160K – 626
2018
Q1 		$160K Buy
32,021
+5,315
+20% +$32K 0.01% 234
2017
Q4 		$166K Buy
26,706
+4,366
+20% +$26.3K 0.01% 215
2017
Q3 		$124K Buy
22,340
+1,413
+7% +$7.3K 0.01% 133
2017
Q2 		$97K Buy
+20,927
New +$93.4K 0.01% 184

ETF Managers Group's FOMX Position: Q1 2020 in Review

ETF Managers Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 114,087 shares — an estimated $374K sold.

ETF Managers Group first reported a position in FOMX in Q2 2017 and held it in 10 quarters. The position peaked at $374K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • ETF Managers Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • ETF Managers Group sold 114,087 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $374K.
  • ETF Managers Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2017 and held it in 10 quarters.
  • ETF Managers Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $374K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on ETF Managers Group's 13F filing for Q1 2020, filed 14 May 2020.